Premium Information is available for this item - Upgrade for $1 a day
6505-01-629-9889
Fentanyl Citrate Transmucosal Lo
6505016299889 016299889 ACTIQ 800MCG 8106992
INC: 77777
January 2023
6

Marketplace 6505-01-629-9889
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-629-9889 5+ Documents (More...)
6505-01-629-9889 5+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-629-9889
/fsg-65/fsc-6505/us 6505-01-629-9889 /fsg-65/fsc-6505/us 6505-01-629-9889 /fsg-65/fsc-6505/us 6505-01

/fsg-53/fsc-5330/it
https//www.nsnlookup.com /fsg-53/fsc-5330/it 5330-15-142-2565 Anello 5330151422565 151422565,8106992 8106992
vendors Request Updated Every Day 5330-15-142-2565 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-629-9889
Fentanyl Citrate Transmucosal Lo 016299889 Upgrade your Account Upgrade 6505-01-629-9889Fentanyl
Citrate Transmucosal Lo6505016299889 016299889 ACTIQ /www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-
Fentanyl Citrate Transmucosal Lo 016299889 Upgrade your Account Upgrade 6505-01-629-9889Fentanyl
Citrate Transmucosal Lo6505016299889 016299889 ACTIQ /www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-
Fentanyl Citrate Transmucosal Lo 016299889 Upgrade your Account Upgrade 6505-01-629-9889Fentanyl
Citrate Transmucosal Lo6505016299889 016299889 ACTIQ /www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-
Restrictions 6505-01-629-9889
6505-01-629-9889 is a Fentanyl Citrate Transmucosal Lo that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
End Users 6505-01-629-9889
- Australia (ZA01)
- Effective Date:
- 1 Jul 2014
Approved Sources 6505-01-629-9889
- Part Number
- Manufacturer
- Status
- ACTIQ 800MCG
- Manufacturer
- 1NXE0 - Cephalon Inc. (Active)
- Primary Buy
- Primary Buy
- 8106992
- ZBF76 - Anspec Pty Ltd (Active)
- Secondary Buy
- Secondary Buy
Datasheet 6505-01-629-9889
- Characteristic
- Specifications
- FIIG
- Specifications
- A23900
- Part Name Assigned By Controlling Agency [CXCY]
- Actiq Lozenge W/ Integral Applicator 800 Mcg
- Unit Package Quantity [AGUC]
- 9
- Special Features [FEAT]
- Similar Decs. And Dosage To Pre.Est. Nsn 6505-01-578-9755
Similar Supply Items to 6505-01-629-9889


















Freight Information 6505-01-629-9889
6505-01-629-9889 has freight characteristics managed by Australia.. 6505-01-629-9889 has a variance between NMFC and UFC when transported by rail and the description should be consulted.